Literature DB >> 9428348

The cytoskeleton and brain tumour cell migration.

S L Maidment1.   

Abstract

Although the mechanics of brain tumour cell motility are poorly documented, studies in other cell types-notably fibroblasts--have revealed cell motility to be dependent on dynamic remodelling of the actin cytoskeleton. Initially, protrusion of membrane microspikes or lamellipodia is associated with actin polymerisation and probably involves membrane-anchored myosin I. Subsequent attachment of the cell's leading edge to the substratum is via actin-anchored adhesion complexes and finally generation of tractile forces is believed to involve the formation of contractile actin structures. Co-ordination of these events is even less well understood but recent evidence points to the involvement of the Ras family of GTP-binding proteins, particularly the cdc42-Rac-Rho cascade which appears to choreograph membrane extension and attachment. Furthermore, the growth associated protein GAP-43 (neuromodulin) has recently been demonstrated in brain tumour cells. This protein stabilises membrane protrusions during neuritogenesis in response to external trophic factors and is likely to have a similar role in brain tumour cell invasion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9428348

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

1.  Assessing the cytoskeletal system and its elements in C6 glioma cells and astrocytes by atomic force microscopy.

Authors:  Dexiang Zhou; Xiaodan Jiang; Ruxiang Xu; Yingqian Cai; Jiliang Hu; Gang Xu; Yuxi Zou; Yanjun Zeng
Journal:  Cell Mol Neurobiol       Date:  2008-03-04       Impact factor: 5.046

2.  Hyaluronate receptors mediating glioma cell migration and proliferation.

Authors:  Y Akiyama; S Jung; B Salhia; S Lee; S Hubbard; M Taylor; T Mainprize; K Akaishi; W van Furth; J T Rutka
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

3.  Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis.

Authors:  L Mariani; C Beaudry; W S McDonough; D B Hoelzinger; T Demuth; K R Ross; T Berens; S W Coons; G Watts; J M Trent; J S Wei; A Giese; M E Berens
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 4.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 5.  Genes that regulate metastasis and angiogenesis.

Authors:  C P Webb; G F Vande Woude
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

6.  Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.

Authors:  Dominique B Hoelzinger; Luigi Mariani; Joachim Weis; Tanja Woyke; Theresa J Berens; Wendy S McDonough; Andrew Sloan; Stephen W Coons; Michael E Berens
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

7.  Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells.

Authors:  C B Ransom; J T O'Neal; H Sontheimer
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

8.  B-FABP-expressing radial glial cells: the malignant glioma cell of origin?

Authors:  Raja Mita; Jeffrey E Coles; Darryl D Glubrecht; Rohyun Sung; Xuejun Sun; Roseline Godbout
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

9.  Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines.

Authors:  Hannah C Cheung; Tao Hai; Wen Zhu; Keith A Baggerly; Spiridon Tsavachidis; Ralf Krahe; Gilbert J Cote
Journal:  Brain       Date:  2009-06-08       Impact factor: 13.501

10.  Motexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids.

Authors:  Steen J Madsen; Marlon S Mathews; Even Angell-Petersen; Chung-Ho Sun; Van Vo; Rogelio Sanchez; Henry Hirschberg
Journal:  J Neurooncol       Date:  2008-09-06       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.